Kenneth I. Moch, Director at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 115 shares at $0.35 ($40) on 2023-06-14, disclosed to the SEC on 2023-06-15.
Open-market sale of $40 ZYNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CMRX | SELL | 2014-02-26 | $221K | — | Filing → |
| CMRX | SELL | 2014-02-03 | $19K | — | Filing → |
| CMRX | SELL | 2013-11-19 | $39K | — | Filing → |